Impact of pharmacotherapy on interstage outcomes in single ventricle infants

Congenital Heart Disease

Volumn 6, Issue 4, 2011, Pages 286-293

  Moffett, Brady S ^a   Mattamal, Raphael ^b   Ocampo, Elena C ^b   Petit, Christopher J ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Medications; Single ventricle; Weight gain; z score

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANALGESIC AGENT; ANTIBIOTIC AGENT; CAPTOPRIL; CHLOROTHIAZIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; ENOXAPARIN; FUROSEMIDE; LORAZEPAM; METHADONE; PROPRANOLOL; PROTON PUMP INHIBITOR; RANITIDINE; SOTALOL; SPIRONOLACTONE; URSODEOXYCHOLIC ACID; VITAMIN;

ARTICLE; ATRIOVENTRICULAR CANAL; BODY GROWTH; DRUG MEGADOSE; FEMALE; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HOSPITAL DISCHARGE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MAJOR CLINICAL STUDY; MALE; NORWOOD PROCEDURE; OUTPATIENT CARE; PALLIATIVE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

AMBULATORY CARE; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; DOUBLE OUTLET RIGHT VENTRICLE; DRUG THERAPY, COMBINATION; FEMALE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HOSPITALS, PEDIATRIC; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; LINEAR MODELS; LOGISTIC MODELS; MALE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TEXAS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 79960673760     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2011.00536.x     Document Type: Article

References (27)

1. Davis D, Davis S, Cotman K, etal. Feeding difficulties and growth delay in children with hypoplastic left heart syndrome versus d-transposition of the great arteries. Pediatr Cardiol. 2008;29:328-333.
2. Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition. 2006;22:237-244.
3. Vogt KN, Manlhiot C, Van Arsdell G, Russell JL, Mital S, McCrindle BW. Somatic growth in children with single ventricle physiology impact of physiologic state. J Am Coll Cardiol. 2007;50:1876-1883.
4. Anderson JB, Beekman RH 3rd, Border WL, etal. Lower weight-for-age z score adversely affects hospital length of stay after the bidirectional Glenn procedure in 100 infants with a single ventricle. J Thorac Cardiovasc Surg. 2009;138:397-404.e1.
5. Hehir DA, Dominguez TE, Ballweg JA, etal. Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg. 2008;136:94-99, 99.e1-3.
6. Sano S, Huang SC, Kasahara S, Yoshizumi K, Kotani Y, Ishino K. Risk factors for mortality after the Norwood procedure using right ventricle to pulmonary artery shunt. Ann Thorac Surg. 2009;87:178-185; Discussion 185-186.
7. Ghanayem NS, Hoffman GM, Mussatto KA, etal. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg. 2003;126:1367-1377.
8. Ghanayem NS, Hoffman GM, Mussatto KA, etal. Perioperative monitoring in high-risk infants after stage 1 palliation of univentricular congenital heart disease. J Thorac Cardiovasc Surg. 2010;140:857-863.
9. Simsic JM, Bradley SM, Stroud MR, Atz AM. Risk factors for interstage death after the Norwood procedure. Pediatr Cardiol. 2005;26:400-403.
10. Srinivasan C, Sachdeva R, Morrow WR, etal. Standardized management improves outcomes after the Norwood procedure. Congenit Heart Dis. 2009;4:329-337.
11. Checchia PA, Larsen R, Sehra R, etal. Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome. Ann Thorac Surg. 2004;77:477-483; Discussion 483.
12. Jeffries HE, Wells WJ, Starnes VA, Wetzel RC, Moromisato DY. Gastrointestinal morbidity after Norwood palliation for hypoplastic left heart syndrome. Ann Thorac Surg. 2006;81:982-987.
13. Skinner ML, Halstead LA, Rubinstein CS, Atz AM, Andrews D, Bradley SM. Laryngopharyngeal dysfunction after the Norwood procedure. J Thorac Cardiovasc Surg. 2005;130:1293-1301.
14. Sarajuuri A, Jokinen E, Puosi R, etal. Neurodevelopmental and neuroradiologic outcomes in patients with univentricular heart aged 5 to 7 years: related risk factor analysis. J Thorac Cardiovasc Surg. 2007;133:1524-1532.
15. Prendiville TW, Barton LL, Thompson WR, Fink DL, Holmes KW. Heterotaxy syndrome: defining contemporary disease trends. Pediatr Cardiol. 2010;31:1052-1058.
16. Li JS, Yow E, Berezny KY, etal. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. 2007;116:293-297.
17. Hsu DT, Zak V, Mahony L, etal. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333-340.
18. Petit C, Fraser C, Mattamal R, Slesnick T, Cephus C, Ocampo E. The Impact of a Dedicated Single Ventricle Home Monitoring Program on Interstage Somatic Growth, Interstage Attrition and One-Year Survival. J Thorac Cardiovasc Surg. 2011 (in press).
19. Bartram U, Grunenfelder J, Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg. 1997;64:1795-1802.
20. Tweddell JS, Hoffman GM, Fedderly RT, etal. Patients at risk for low systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg. 2000;69:1893-1899.
21. Wernovsky G, Rome JJ, Tabbutt S, etal. Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis. 2006;1:10-26.
22. Shaw NJ, Wilson N, Dickinson DF. Captopril in heart failure secondary to a left to right shunt. Arch Dis Child. 1988;63:360-363.
23. Montigny M, Davignon A, Fouron JC, Biron P, Fournier A, Elie R. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt. Am J Cardiol. 1989;63:631-633.
24. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514-520.e4.
25. Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic drug therapy in children: a review of current options. Ann Pharmacother. 2005;39:706-711.
26. Treadway AK, Craddock D, Leff R. Practices of pharmacies that compound extemporaneous formulations. Am J Health Syst Pharm. 2007;64:1403-1409.
27. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LT. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 2003;92:1486-1489.